Page results
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the abdomen.
-
UCLH is committed to following a set of principles on how the trust will use routinely collected patient data for research. The principles will enable vital health research to take place, while at the same time protecting and using clinical data as patients would expect.
-
This page has been written for patients having proton beam therapy (PBT) at University College Hospital (UCH).
-
This page is for parents and carers whose child is having radiotherapy treatment to the neck and chest.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the neck, chest, abdomen, and pelvis.
-
This information has been written to help you now that your radiotherapy treatment is finishing.
-
This page has been written for patients at Eastman Dental Hospital who are undergoing intravenous sedation.
-
This page is for patients who are having stereotactic ablative body radiotherapy (SABR) for lung cancer.
-
This page has been written for patients who are having a course of superficial radiotherapy for a skin tumour (such as a basal cell carcinoma or squamous cell carcinoma), or some other skin condition.
-
This page has been written for patients who wish to find out more about a new procedure for epilepsy that does not involve removing parts of brain, known as EASEE® (Epicranial Application of Stimulation Electrodes for Epilepsy)
File results
-
FOI2017266 Viscosupplementation injections
-
FOI2017263 Self-administration of medicines policies and carers policies
-
FOI2017295 A&E attendances for acopia
-
FOI2017296 Contracts for the redevelopment of the Middlesex annexe and Royal London Hospital for Integrated Medicine
-
FOI2017307 Televisions for patients
-
FOI2017314 Deep brain stimulation procedures
-
FOI2017300 Sustainability and transformation
-
FOI2017315 Expenditure on reconciliation and validation of incomplete and missing RTT codes
-
FOI2017320 Patients with Multiple Sclerosis treated with MS disease modifying drugs
-
FOI/2023/0226 - Treatment with Nivolumab